T1	Participants 590 623	Patients with multivessel disease
T2	Participants 1663 1763	Among diabetic patients who were being treated with insulin or oral hypoglycemic agents at base line
T3	Participants 58 91	patients with multivessel disease
T4	Participants 327 364	patients with coronary artery disease
T5	Participants 408 464	patients with multivessel disease suitable for treatment
